Biocon shines on getting nod to sell BFI Business to Biocon Biologics

19 Jun 2019 Evaluate

Biocon is currently trading at Rs. 251.55, up by 8.45 points or 3.48% from its previous closing of Rs. 243.10 on the BSE.

The scrip opened at Rs. 244.05 and has touched a high and low of Rs. 252.50 and Rs. 242.80 respectively. So far 164795 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 359.18 on 26-Sep-2018 and a 52 week low of Rs. 238.90 on 18-Jun-2019.

Last one week high and low of the scrip stood at Rs. 259.00 and Rs. 238.90 respectively. The current market cap of the company is Rs. 30012.00 crore.

The promoters holding in the company stood at 60.67%, while Institutions and Non-Institutions held 22.28% and 17.05% respectively.

Biocon has received approval for sale of Branded Formulations India (BFI) Business of the Company on a 'going concern' basis to Biocon Biologics India (BBIL), a wholly owned subsidiary. The transfer of BFI business on slump sale basis will lead to consolidation of marketing and manufacturing activities relating to BFI business under a single entity with common leadership and achieve synergies / value accretion for the group. The Board of Directors of the Company at its meeting held on June 17, 2019 has approved the same.

Biocon is India’s largest and Asia’s leading Biotechnology Company with a strategic focus on biopharmaceuticals and research services. It is a fully integrated, innovation-driven biopharma enterprise offering affordable solutions for chronic diseases to patient's worldwide.

Biocon Share Price

365.25 0.00 (0.00%)
28-Jan-2026 10:09 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1621.35
Dr. Reddys Lab 1232.15
Cipla 1321.65
Zydus Lifesciences 887.40
Lupin 2132.40
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×